Huachansu & Gemcitabine in Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Pancreatic Cancer
Interventions
DRUG

Gemcitabine

1,000 mg/m2 once a week for 3 weeks then 1 week off (28 Day Cycle).

DRUG

HuaChanSu

20 mL/m2 for total 500 mL given as a 2 hour infusion, 5 days a week for 3 weeks then one week off (28 Day Cycle).

DRUG

Placebo

500 ml saline only administered as a 2 hour infusion by central line.

Trial Locations (1)

Unknown

Cancer Hospital Fudan University, Shanghai

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00837239 - Huachansu & Gemcitabine in Pancreatic Cancer | Biotech Hunter | Biotech Hunter